Skip to main content

What the FDA labels say about taking them together

Clarithromycin and fesoterodine

Fesoterodine's FDA label of April 7, 2026 names clarithromycin in its drug interactions section; the clarithromycin label PlainMeds reads does not name fesoterodine. The fesoterodine label: “Doses of Toviaz greater than 4 mg are not recommended in adult patients taking strong CYP3A4 inhibitors, such as ketoconazole, itraconazole, and clarithromycin.”

Check it at the source: the clarithromycin FDA label on DailyMed (effective April 9, 2026, Solaris Pharma Corporation); the fesoterodine FDA label on DailyMed (effective April 7, 2026, Pfizer Laboratories Div Pfizer Inc).

What does the clarithromycin label say about fesoterodine?

Clarithromycin's label (effective April 9, 2026) does not name fesoterodine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Clarithromycin), Solaris Pharma Corporation, effective April 9, 2026 (SPL set 4d42821d-ce7a-7d64-e063-6294a90a0875), via openFDA; the full label on DailyMed

What does the fesoterodine label say about clarithromycin?

Fesoterodine label, drug interactions

Doses of Toviaz greater than 4 mg are not recommended in adult patients taking strong CYP3A4 inhibitors, such as ketoconazole, itraconazole, and clarithromycin [see Dosage and Administration (2.5) ].

Source: FDA drug label (Toviaz), Pfizer Laboratories Div Pfizer Inc, effective April 7, 2026 (SPL set 5be745f0-8ae7-4c3c-9962-37d6263326f1), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

26Clarithromycin generic labelers
11Fesoterodine generic labelers
ClarithromycinFesoterodine
Labeled forBacterial infections, Acid reflux and ulcersOveractive bladder
Boxed warningNoNo
Pharmacy cost (NADAC)$0.466 per tablet 500 mg tablet$0.794 per tablet 4 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?